Bio Tech, Healthcare & Pharmaceuticals
The Bio Tech industry faces an increasing challenge to meet investors’ concerns for future sales and profits. To minimize risk, companies must grow a strong and diversified product pipeline. Expert oversight is required to manage the development, approval and testing phases of multiple drug candidates. Bio Tech companies must navigate an increasingly rigorous drug approval process and speed time to market without compromising ethical and safety standards.
SMART EPM for Bio Tech empowers pharmaceutical companies to:
- Develop a diversified pipeline of drug candidates
- Decrease time to market and cost of development, testing and approval
- Create a strong IT infrastructure to support management of complex development and administration functions